February 21, 2025

Oyster Proteins Supercharge Common Antibiotics' Power

New research reveals that antimicrobial proteins extracted from Sydney Rock Oyster hemolymph can enhance conventional antibiotic effectiveness up to 32-fold against drug-resistant bacteria while showing no toxicity to human cells.

Conexiant

February 21, 2025

CDC: Measles Cases Surge Amid Texas Outbreak

Measles cases in the U.S. surged from 14 to 93 in one week, with 95% of infections in unvaccinated or immunity-unknown individuals, per the CDC.

Reuters

February 21, 2025

Study Finds Diabetes Fuels Antibiotic Resistance

A study in Science Advances shows diabetes accelerates antibiotic resistance in Staphylococcus aureus infections, highlighting hyperglycemia's role in promoting resistant bacterial strains.

Conexiant

February 20, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 19, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 17, 2025

FDA Approves GSK’s 5-in-1 MenABCWY Vaccine

FDA approves GSK’s Penmenvy, a 5-in-1 meningococcal vaccine for adolescents and young adults, targeting five major serogroups of Neisseria meningitidis that cause invasive meningococcal disease.

Conexiant

February 17, 2025

Physician Turnover After Private Equity Exits

Researchers found physicians in private equity-exiting practices were less likely to stay and more likely to join larger groups within 2 years.

Conexiant

February 17, 2025

FDA Approves GSK’s 5-in-1 MenABCWY Vaccine

FDA approves GSK’s Penmenvy, a 5-in-1 meningococcal vaccine for adolescents and young adults, targeting five major serogroups of Neisseria meningitidis that cause invasive meningococcal disease.

Conexiant

February 14, 2025

New Blood-Clotting Disorder Linked to Antibodies

Scientists have identified a chronic blood-clotting condition characterized by treatment-resistant thrombosis and linked to monoclonal antibodies targeting platelet factor 4, according to a new study.

Conexiant